NEW YORK LIFE INVESTMENT MANAGEMENT LLCNEW YORK LIFE INVESTMENT MANAGEMENT LLC

Institutional investor · Portfolio as of Q1 2021

SEC EDGAR SourceSEC Filings

Top Holdings31 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
IQSUIQSU
ETF

NEW YORK LIFE INVESTMENTS ET

11.1M$375.4M22.6%$28.34+11.45%
4 qtrssince 2020-Q2
Increased
68
CLRGCLRGDelisted
ETF

IQ U.S. Large Cap ETF

9.4M$289.9M17.5%$21.49+38.48%
9 qtrssince 2019-Q1
Decreased
0
IQINIQINDelisted
ETF

NYLI 500 International ETF

7.7M$245.9M14.8%$19.36+44.14%
9 qtrssince 2019-Q1
Decreased
0
IQSIIQSI
ETF

NEW YORK LIFE INVESTMENTS ET

5.6M$159.5M9.6%$20.93+18.37%
4 qtrssince 2020-Q2
Increased
71
HFXIHFXI
ETF

NYLI FTSE INTERNATIONAL EQUITY CURRENCY NEUTRAL ETF

6.6M$158.7M9.6%$15.66+28.95%
9 qtrssince 2019-Q1
Decreased
0
CSMLCSMLDelisted
ETF

IQ U.S. Small Cap ETF

4.6M$158.4M9.5%$23.75+38.08%
9 qtrssince 2019-Q1
Decreased
0
HYLVHYLVDelisted
ETF

IndexIQ ETF Trust IQ S&P High Y

2.3M$57.6M3.5%$24.15
4 qtrssince 2020-Q2
Increased
57
GVIGVI
ETF

ISHARES TR

265,051$30.4M1.8%$101.39-2.00%
9 qtrssince 2019-Q1
Unchanged
0
MGCMGC
ETF

VANGUARD MEGA CAP ETF

206,118$28.9M1.7%$116.75+12.19%
4 qtrssince 2020-Q2
Increased
54
IEFAIEFA
ETF

ISHARES CORE MSCI EAFE ETF

292,055$21M1.3%$56.49+9.03%
4 qtrssince 2020-Q2
Increased
62
SHVSHV
ETF

ISHARES SHORT TREASURY BOND

157,474$17.4M1.0%$90.67+2.52%
9 qtrssince 2019-Q1
Unchanged
0
AGGAGG
ETF

ISHARES TR

124,824$14.2M0.9%$98.96-2.81%
4 qtrssince 2020-Q2
Increased
42
SCHZSCHZ
ETF

SCHWAB US AGGREGATE BOND ETF

263,338$14.2M0.9%$23.68-2.87%
4 qtrssince 2020-Q2
Increased
42
VOVO
ETF

VANGUARD MID-CAP ETF

55,230$12.2M0.7%$46.96+8.84%
4 qtrssince 2020-Q2
Increased
59
IWDIWD
ETF

ISHARES TR RUSSELL 1000 VALUE INDEX FUND

62,388$9.5M0.6%$102.41+35.38%
6 qtrssince 2019-Q4
Unchanged
0
MGVMGV
ETF

VANGUARD WORLD FD

85,375$8.1M0.5%$77.87+9.43%
4 qtrssince 2020-Q2
Increased
53
SHYGSHYG
ETF

ISHARES TR

165,795$7.6M0.5%$32.64+3.10%
4 qtrssince 2020-Q2
Increased
46
BKLNBKLN
ETF

INVESCO EXCH TRADED FD TR II

290,981$6.4M0.4%$14.98+4.35%
9 qtrssince 2019-Q1
Increased
40
BILBIL
ETF

SPDR BLOOMBERG 1-3 MONTH T-B

64,581$5.9M0.4%$76.77+1.88%
9 qtrssince 2019-Q1
Unchanged
0
VCITVCIT
ETF

VANGUARD INT-TERM CORPORATE

55,770$5.4M0.3%$67.77+13.71%
9 qtrssince 2019-Q1
Unchanged
0
$1.7B
AUM
31
Positions
Q1 2021
Filing
Rating · 4.0
Quarterly Portfolio Change
-21%Q4'19$681M-7%Q1'20$633.5M+49%Q2'20$946.4M+17%Q3'20$1.1B+35%Q4'20$1.5B+11%Q1'21$1.7B
Activity profile
$ moved · Q1'21
New8%Increased64%Decreased24%Exited5%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.2 years
<1Q19%1-4Q35%1-2Y0%2Y+45%

NEW YORK LIFE INVESTMENT MANAGEMENT LLC manages $1.7B across 31 positions as of Q1 2021. Top holdings: IQSU (22.6%), CLRG (17.5%), IQIN (14.8%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 4/5.0.

Q1 2021 Summary

Active quarter - 6 new positions, 1 exits, 13 increased. Top move: IQSI (INCREASED, conviction 71). Portfolio: $1.7B across 31 positions.

Top holdings by portfolio weight

Total AUM$2B
IQSU22.62%
CLRG17.47%
IQIN14.81%
IQSI9.61%
HFXI9.56%
CSML9.55%
HYLV3.47%
GVI1.83%
MGC1.74%
IEFA1.27%
Other1.05%

Portfolio allocation by GICS sector

Sectors1
Unknown100.00%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Unknown
Compare DNA across all funds
7-dimension quality assessment
Strong(4.0 / 5.0)
Track Record70
Conviction40
Concentration43
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
8Q
USHYUSHYISHARES BROAD USD HIGH YIELD
Q3 2024 Q2 2026+906,416 shares+$33.7M
7Q
APHAPHAMPHENOL CORP-CL A
Q4 2024 Q2 2026+10,995 shares+$19.8M
7Q
ATOATOATMOS ENERGY CORP
Q4 2024 Q2 2026+2,574 shares+$1.1M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used